Research Article (Open access) |
---|
Int. J. Life. Sci. Scienti. Res.,
4(3):
1834-1843,
May 2018
Comparative Assessment of Ginger and
Cassava Starch as a Binder on Ibuprofen Tablet Formulation
Ordu JI*, Onyemelukwe
JI
Department of Pharmaceutics and
Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, University of
Port Harcourt, Nigeria
*Address for Correspondence: Dr. Ordu John Ikechi, Faculty of
Pharmaceutical Sciences, University of Port Harcourt, Rivers State, Nigeria
ABSTRACT- Using the wet
granulation method of tablet formulation, ibuprofen tablets were formulated
with binder concentration of 2%, 4% and 6% w/w respectively. The compressional, mechanical and dissolution properties were
analyzed using density, crushing strength and dissolution methods. The result
obtained shows that tablets made with ginger starch had acceptable crushing
strength and dissolution rate. The disintegration time for 2%, 4%, and 6% w/w
ginger starch were 22.25, 17.07 and 33.17 minutes respectively and that for
cassava starch 34.24, 29.16 and 33.35 minutes respectively. The 2% w/w of the
ginger and cassava starches did not fall within the standard limit of the
hardness test (4 - 8 kg) but rather values of 8.55 kg and 8.45 kg respectively
was obtained and this may be linked to the thresh hold of the binders
concentration not being attained. All the formulations passed the qualitative
analysis but that consisting of 4% w/w ginger starch performed excellently in
the entire tests hence ginger starch of such concentration could be a very
suitable excipient for ibuprofen tablet formulation
as compared to cassava starch of the same percentage composition.
Key words: Ginger, Cassava, Ibuprofen, Starch, Tablet, Natural biodegradable biopolymer
INTRODUCTION- Binders as agents
impart cohesive qualities to powdered material during the production of tablet.
They impact such properties to the tablet formulation by ensuring that the
tablet remains intact after compression as well as improving free powder flowing
quality [1]. Binders have been used as solutions and in dry form
depending on nature of another ingredient in the formulation and method of
preparation. The choice of a particular binding agent depends on the binding
force required, compatibility with other ingredients, particularly the active
pharmaceutical ingredient (API) [2].
Important materials commonly
used as binders are starch, gelatin, natural gum, sugar, acacia, polyethylene
glycol, water etc [3]. Starch is the most common binder and pharmaceutical
excipient used in tablet formulation to impart
cohesion on powder mix during tablet formulation. Starch as one of the most
abundant organic chemicals on earth is found in the leaves of green plants and
on the plastids where it is synthesized from seeds, roots, and tubers of most
plants serving as the chemical storage form of energy [4].
Starch is a natural
biodegradable biopolymer which has wide industrial application, a
quantitatively important digestible polysaccharide regarded as nutritionally superior
to low molecular weight carbohydrate or sugar [5].Maize and potato
starch has been in common use and recently cassava starch [6].
Another type of starch currently under study is ginger starch as a binder in
the pharmaceutical industry. The type and binder concentration could impart a
direct effect on tablet properties such as crushing strength, friability,
disintegration and tablet dissolution.
Ginger (Zingiber officinale) is an herbaceous perennial plant belonging to
the order scitaminaceae and family Zingiberaceae.
Harvest of natural ginger is determined by the age of the leaves and
bulb size and it contains such compounds as starch, fat, gingerol
and volatile oil. The starch is mainly used as an indicator, the excipient in tablet formulation and also for other purposes
where it serves as a thickening agent and binding agent [7].
Cassava (Manihot esculenta) is a perennial shrub
with an edible root which grows in tropical and sub-tropical areas of the
world. Cassava is propagated by stem cutting [8] and the major
constituent is starch especially from the cassava tuber and this starch is
often recommended for use in extruded snacks for improved expansion. The
cassava starch is also used as a thickener in food not subjected to rigorous
processing condition. It is very bland in flavor hence used in processed baby
foods and as a filer material and binding agents in the confectionary industry [9].
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAIDs), a first member of
the propionic acid derivative which occurs as a white
powder or crystals with a characteristic odour.
Fig. 1: Chemical tructure of Ibuprofen
Ibuprofen is soluble in
aqueous solution of alkali hydroxide and carbonate but slightly soluble in
water and has a melting point of about 76°C [10]. Ibuprofen has a
prominent analgesic and anti-pyretic
effect which is due to the inhibitory action on cyclooxygenases
involved in the synthesis of prostaglandin that plays important role in the
production of pain, fever, and inflammation [11].
Ibuprofen is well absorbed
orally, peak serum concentration is reached within 1 - 2 hours after drug
administration and the drug is eliminated within 24 hours after the last dose
through metabolism. The dose of ibuprofen for an adult is 1.2 g daily in
divided doses, while that for children is 20 mg/kg body weight daily, but not
above 500mg for children with weight less than 30kg, as overdose may lead to
toxicity such as acute renal failure, aplastic anaemia, neutropenia and
thrombocytopenia.
Ibuprofen decreases the
effect of aspirin by blocking the active site of platelet cyclo-
oxygenase, hence it should be administered 8 hours
before aspirin, or at least 2- 4 hours after aspirin. Ibuprofen is available in
the following dosage forms as tablet, capsules, chewable tablets, and oral
suspension and usually manufactured as 200 mg or 400 mg ibuprofen in a tablet
and 100mg/50mg in oral suspension and it should be taken after a meal because
it can lead to damage of stomach or intestinal lining if taken before a meal.
Tablets are solid
preparation each containing a single dose of one or more active ingredients and
usually obtained by compressing uniform volumes of particles. It is the most
popular dosage form in existence among all dosage forms because of the
convenience of self-administration, chemical and physical stability, cheapness,
versatile way of use and delivery, compactness and ease of manufacturing [12].
Certain numbers of chemically inert materials known as adjunct or excipients are added to the active pharmaceutical
ingredient and their classification is based on their processing functions and
finished products such as binders, lubricants, glidants,
disintegrants, etc. Such excipients
should be bound with certain quality criteria as non- toxic, physiologically
inert, relatively cheap and acceptable to regulating agencies in all countries [13].
The aim of this study is to evaluate and compare the binding activity of
extracted ginger and cassava starch on ibuprofen tablet formulation.
MATERIALS AND METHODS
Experimental Materials-
Ibuprofen powder (BDH, England), magnesium stearate,
lactose, maize starch, talc, pH meter (Jenway 3510
England), Electronic balance (AdventurerTm
AR 2130 England), dissolution Apparatus (Erweka TBH
600, Germany), disintegration apparatus (Erweka ZT,
122, Germany), UV spectrometer (Jenway 6405,
England), fribilator (Erweka
TAR 220, Germany), hardness tester (ErwekaTBH 100,
Germany), Ginger and cassava starch (processed in pharmaceutical technology
laboratory, University of Port Harcourt, Nigeria.
Solubility
determination of ibuprofen powder- A 0.1 g
quantity of ibuprofen powder was weighed (Table 1) and each transferred into
six test tubes, various solvents (acetone, sodium hydroxide, water, n- hexane,
HCL, and chloroform) (10 ml each) were respectively introduced into each of the
six test tubes, containing the drugs,
shaken and observed for solubility.
Table 1: Preparation of Ibuprofen Granules
Ingredients |
Weight per tablet
(mg) |
Weight in 150 tablets
(g) |
|||
Ibuprofen |
400 |
60 |
|||
Maize
starch |
1.5% w/v |
1.5% w/v |
|||
Lactose |
120 |
10 |
|||
Ginger/Cassava
starch |
2% w/v,
4% w/v and 6% w/v |
Qs |
|||
|
Exo
disinfectants |
|
|
||
Lubricants/Glidants |
|
|
|||
Dried
maize starch |
1.5% w/v |
1.5% w/v |
|||
Magnesium stearate |
2% w/v |
2% w/v |
|||
TALC |
3% w/v |
3% w/v |
|||
Adopting the technique of
wet granulation method of the tablet formulation, ibuprofen granules were made
based on the formula in Table 1. Ginger starch was employed as the test binder
while cassava starch was employed as the reference standard all incorporated in
various concentrations as 2, 4, and 6% w/v.
Ibuprofen powder was geometrically diluted with dried maize starch
(the disintegrant) in a porcelain mortar. The binder
paste prepared from the ginger and cassava starches respectively were
incorporated into the content of the mortar until a wet coherent mass was
obtained. The damp mass was then passed through a 2mm sieve aperture to break
down the mass and then dried at 50°C in the oven (Mermett
U- 27, Germany) for 30 minutes. The granular mass obtained was again passed through a 1mm sieve aperture
to ensure uniformly sized granules and this was further dried at 50°c for 1
hour. The dried granules were incorporated with the exo-excipients
(disintegrant, lubricant and glidant)
as dried maize starch, magnesium stearate and talc
respectively.
Physico Technical Characterization of Granules
Flow rare Determination- Adopting
the flow through the hoppers method, a funnel with an efflux tube length (3.9 cm)
and orifice diameter (1.2 cm) was clamped on the retort stand and the distance
between the funnel and surface is set at 6cm. Required weight of 30 g of
granules per batch were allowed to pass through the orifice and the time taken
for it to pass through was recorded. The flow rate was determined using the
relation
Quantity of granules (g)
flow per unit time (sec)= M
(g) / T (sec)
Where, M = Weight (Mass) of granules in the funnel
T = Time of
granule flow through the hopper
Mean of the triplicate readings was taken as the flow rate of the
granules. Characterization of other physico-technical
properties such as angle of repose, bulk and tapped density, Hausner’s quotient and Carr’s index were carried out
adopting the standard procedures.
Addition of Exo-excipients- The exo excipients [exo-disintegrant (dried maize starch), lubricant (magnesium
stearate) and glidant
(talc)], were added to the granule based on the formula as in Table 1 and the
granules properly blended to obtain a randomly mixed powder suitable for
Pharmaceutical tablet formulation.
Compression of tablets-
After the addition of exo-excipients,
the granules were compressed into a tablet using the single punch tableting machine (Erweka E PHI,
Germany) at varying pressure until best tablet was formed. The formed tablets
were left for 24 hours before evaluation to allow for elastic recovery.
Quality control of tablets
Weight variation- The weights of 20 randomly selected tablets were determined as a
whole and then individually using electronic balance (Adventurer Tm England)
and the mean weight calculated. The variation in weight of the individual
tablets from the mean was determined.
Friability Test- Ten tablets were randomly selected and placed in a sieve and loose
dust removed with the aid of a soft brush. The dedusted
tablets were weighed and caused to cascade in the drum of a fribilator
rotated at 25 rpm for 4 minutes. The tablets were again dedusted
and reweighed. The percentage friability was determined using the formula:
% Friability= Initial weight –
final weight X 100/ Initial weight
Crushing Strength (Hardness)
test- The crushing strength of each of 10
tablets was determined using the Erweka TBH Germany
hardness tester and the mean crushing strength determined.
Disintegration test- The disintegration rate of six tablets randomly selected from each
batch was individually determined in BP specified apparatus (Erweka ZT 122, Germany) containing purified water at 37 ± 0.5°c
and the mean disintegration time was calculated.
Preparation of standard calibration curve- 100 ml of pure ibuprofen powder was placed in a 100 ml volumetric
flask dissolved in 0.1 N NaOH and made up to mark
with the same solvent. Various dilutions of the stock were made to obtain 0.01,
0.02, 0.03, 0.04, 0.05 and 0.06 mg% with 0.1 N NaOH
and the absorbance determined using UV spectrometer at 228 nm (wavelength for
ibuprofen). A standard calibration curve of absorbance against concentration
was plotted.
Dissolution test- The
dissolution rates of the active drug from the tablet were determined using USP
apparatus II (paddle). A 900 ml of freshly prepared dissolution medium (0.1N NaOH) was transferred into the dissolution jar and
maintained at 37 ± 0.5°C. The paddles were caused to rotate at 50 rpm. Samples
were withdrawn at 10, 20, 30, 40, 50 and 60 minutes and analyzed spectrophotometrically (Jenway 6405
U V, England) for ibuprofen at 228 nm. 10 ml of samples removed for analysis
were replaced immediately with fresh aliquot of the dissolution medium and the
percentage drug dissolved calculated based
on calibration curve result (Beer Lamberts plot).
Concentration = slope X absorbance ± intercept
Amount of drugs released
(mg/ml)= Concentration X Dissolution bath volume X Dilution factor
Percentage
drug dissolved= Amount dissolved in Time (t) X
100/ Total amount dissolved
Drug content Determination-
Twenty tablets were randomly selected from each batch, weighed and
crushed to fine powder. The powdered drug (50 mg) was weighed and transferred
into a 50 ml volumetric flask and dissolved with 0.1 N NaOH
shaken and made up to volume with same solvent.
1 ml, 2 ml, 3 ml, 4 ml, 5 ml, and 6ml of the solution was withdrawn and
each made up to 50 ml with 0.1 N NaOH and then
filtered. The drug content was determined by measurement of the absorbance of
the filtrate at 228 nm using the UV- spectrophotometer.
Assay of Ibuprofen- The method involving acid-base titration (stoichiometric
method) was modified and used. Twenty tablets were selected randomly from a
batch of the formulation and weighed. A quantity of the powder equivalent to
0.5 g Ibuprofen was extracted with 20ml chloroform for 15minutes and then
filtered using filter paper. The residue was washed thrice with 10ml each of
chloroform and the filtrate gently evaporated to dryness. The residue was
dissolved in 100 ml of 96% ethanol and the solution titrated against 0.1N NaOH upon addition of 2 drops of phenolphthalein as
indicator. The end point (pink color) was noted and content of ibuprofen
calculated.
RESULTS- The result in below
Table 1 is due the effect of types of binder (ginger and cassava) and the
varied percentage compositions.
Table 2: Physico- technical characterization of
Ibuprofen granules
Granules property |
Binder concentration |
|||||
|
2% G |
4% G |
6% G |
2% C |
4% C |
6% C |
Flow rate (g/sec) |
7.10 ± 0.96 |
6.70 ± 0.85 |
5.90 ± 0.45 |
6.30 ± 0.12 |
5.20 ± 0.12 |
4.50 ± 0.15 |
Angle of Repose ( °) |
27.30 ± 0.64 |
25.60 ± 1.31 |
24.70 ± 3.79 |
27.80 ± 0.21 |
27.30 ± 0.17 |
26.90 ± 0.23 |
Bulk density (g/ml) |
0.68 ± 0.03 |
0.54 ± 0.06 |
0.50 ± 0.01 |
0.74 ± 0.01 |
0.74 ± 0.02 |
0.65 ± 0.00 |
Tapped density (g/ml) |
0.76 ± 0.02 |
0.64 ± 0.00 |
0.56 ± 0.05 |
0.81 ± 0.00 |
0.79 ± 0.01 |
0.72 ± 0.00 |
Hausner’s quotient |
1.12 ± 0.02 |
1.21 ± 0.13 |
1.12 ± 0.09 |
1.11 ± 0.02 |
1.07 ± 0.02 |
1.11 ± 0.01 |
Compressibility index (kg) |
10.79 ± 1.39 |
13.08 ± 9.26 |
13.80 ± 7.11 |
19.97 ± 1.41 |
12.10 ± 1.64 |
17.60 ± 0.31 |
Various solvents were used for the test so as to determine the
suitable medium for dissolution of formulated ibuprofen tablets.
Table 3: Assay and Solubility Profile of Ibuprofen Powder
Test |
Observation |
Inference |
Ig of ibuprofen powder + 10
ml Acetone 1g of ibuprofen powder + 10 ml 0.1 NNaOH Ig of ibuprofen powder + 10
ml water Ig of ibuprofen powder + 10
ml 0.1 N HCl Ig of ibuprofen powder + 10
ml chloroform |
Soluble Soluble Insoluble Insoluble insoluble |
++ ++ -- -- ++ |
++ = Highly soluble or insoluble,
and -- = Insoluble
The formulated tablets based on various percentage compositions of
the binders (ginger and cassava starches) were subjected to physicotechnical
characterization to determine the strength, stability and ability of the formed
tablet to breakdown at certain period of time.
Table 4: Evaluation of
Tablet Properties
Binder conc. |
Hardness (Kg) |
Weight variation (g) |
Friability (% w/v) |
Disintegration time (minutes) |
2%w/w G |
8.55 ±
0.26 |
4.10 |
0.72 |
22.25 |
4%w/w G |
5.54 ±
0.29 |
4.08 |
0.88 |
15.07 |
6%w/w G |
6.37 ±
0.19 |
5.45 |
0.88 |
18.17 |
2%w/w C |
8.45 ±
0.32 |
2.34 |
0.93 |
29.24 |
4%w/w C |
5.80 ±
0.14 |
4.70 |
0.60 |
17.16 |
6%w/w C |
6.60 ±
0.26 |
2.50 |
1.30 |
23.25 |
G=Ginger starch, C=
cassava starch
Fig. 2: Standard calibration curve for pure ibuprofen powder at
228nm
This result in this table shows the effect of the binder and the
binder concentration on the actual content of the active pharmaceutical
ingredient (API) on the formed ibuprofen tablet.
Table 5: Drug Content
for Ibuprofen Tablet Formulation
Concentration of
binder ( % w/v) |
Drug content (mg) |
Percentage drug
content (% w/v) |
Ginger |
||
2 4 6 |
277.6 340.8 372.0 |
90 96 98 |
Cassava |
||
2 4 6 |
250.0 300.0 357.2 |
89 93 94 |
The result in this figure shows the release profile of the API
from tablet batches formulated using varied concentration (2- 6%) of ginger
starch.
Fig. 3: Dissolution Profile of Ibuprofen
from 2 - 6 % G Tablet Batches
The result in this figure shows the release profile of the API
from tablet batches formulated using varied concentration (2- 6%) of cassava
starch.
Fig. 4: Dissolution Profile of Ibuprofen
from 2-6% C Tablet Batches
The result on this table shows the amount of the API that
dissolved from the tablet in the chosen medium (0.1NNaOH) with time (minutes)
using various concentrations (2 - 6% w/w) of ginger and cassava starches.
Table 6:
Dissolution profile of ibuprofen with various Conc. of Ginger and Cassava
starches
Time (minutes) |
% Drug dissolved |
|||||
|
Ginger starch |
Cassava starch |
||||
2% |
4% |
6% |
2% |
4% |
6% |
|
10 |
62.0 |
72.1 |
87.4 |
53.6 |
64.9 |
79.5 |
20 |
63.2 |
77.6 |
89.1 |
56.5 |
68.2 |
80.7 |
30 |
65.9 |
80.5 |
89.8 |
58.7 |
70.7 |
83.3 |
40 |
67.3 |
81.7 |
91.7 |
60.6 |
71.6 |
85.2 |
50 |
68.5 |
83.6 |
92.7 |
62.0 |
73.5 |
87.2 |
60 |
69.4 |
85.2 |
93.7 |
62.5 |
74.5 |
89.3 |
DISCUSSION- Six batches of
ibuprofen granules were formulated containing varying concentration (2% w/v, 4%
w/v, 6% w/v/) of the binding excipients (cassava and
ginger starch). From the evaluation of tablet properties as in Table 4, there
was an improvement in the flow behavior of the granules formed when compared to
the mere powder initially used reference to such characterization properties as
compressibility index and Hausner’s quotient [14]. Also from the results on the
same table, it was observed that the flow rate decreases with increased
percentage composition of the binders (ginger and cassava starches) although
the flow rate of the granules made with ginger starch was higher than that of
the cassava starch in all relative concentrations (2% w/v, 4% w/v and 6%
w/v). The angle of repose from 2% w/v to
6% w/v for ginger starch, ranged from 27.3 - 24.7° while for cassava starch (2%
w/v to 6% w/v) the value varied from 27.8 - 26.9°.
The values range as obtained
for angle of repose indicated excellent flow characteristics of granules made
using extracted ginger starch and already established cassava starch reference
to standard value ranges. The ibuprofen granules formed with ginger starch and
cassava starch has decreased bulk and tapped density with increase in binder
concentration although the bulk density and tapped density values were higher
in cassava starch granules than in ginger starch granules. This may due to the
high porosity and fluffy nature of the cassava starch powder. Despite the
difference in bulk and tapped density all the granules formulated from ginger
and cassava starch had a Hausner’s ratio of < 1.25,
which is comparable to standard values and this is an indication of a good
granule flow property and acceptable compressibility index relative to the
reference standard values and this indicates the possibility of compact tablet
being formed when the starches are incorporated as excipients
in solid dosage formulation.
Quality control tests
involve series of procedures intended to ensure that a formulated product
(pharmaceutical tablets) adheres to defined sets of standards. The test
includes uniformity of weight, crushing strength (hardness), friability, disintegration,
dissolution and assay of drug content. Friability test is an attrition
resistance method that evaluates the characteristics of a formulated tablet
upon subjection to various forces during handling between the productions up to
product administration. From the result, all the batches passed the test except
for 6% w/v cassava starch with a value of 1.30% reference to standard values [15].
Hardness test is an
indication of the compatibility and intrinsic strength of the granules. A range
of 4 to 8 kg has been recommended as values accepted for crushing strength of
tablets [16]. All the tablets passed this test except for 2% w/v
ginger and cassava starch with values of 8.55kg and 8.45 kg respectively. This
may be due to the inadequate threshold of the binder concentration being
attained at 2% w/v concentration.
Disintegration test is a
measure of the time taken for a tablet to be broken down into smaller particles
in a physiological medium. The acceptable requirement for disintegration time
of uncoated tablet is 15 minutes. From Table 4, it was observed that for the
ginger and cassava starches and the composition of the various concentration,
only tablets formed with ginger starch 4%w/v disintegrated without getting to a
the limit specified in reference book,
while others failed the disintegration test. This effect could be as a result
of thin film formation around the granules which could increase the thickness;
hence probably the concentration of the lubricant (magnesium stearate) needs to be adjusted down ward while the disintegrant (maize starch) concentration needs to be
slightly increased to embrace adequate sorption and wicking of aqueous fluid
and hence enhance quick dis integration of formed
tablet [17].
Dissolution studies provide
an insight into the release or absorption of drugs component from a dosage
form. Certain factors that affect drugs dissolution includes the types and
nature of binders, hardness of tablets, surface area and composition, distance
of diffusion, solubility of active drug and the formulation process [18].
The standard dissolution profile for uncovered ibuprofen tablets
stipulates that not less than 85% of the labeled drug content is dissolved
within 60 minutes. From the study, it was observed that all other tablets
formed using other binder concentration (4% w/v and 6% w/v) of ginger and
cassava starch dissolved within stipulated time(<60 minutes) while that
formulated with 2% w/v binder concentrations failed to meet the required
standard. This result could be linked to the binder concentration not being up
to optimum value to impact a binding and disintegrant
property and by not exerting adequate sorption and wicking mechanisms which the
starches under study are assumed to influence although in other concentrations
(4% and 6%) the ginger starch had better impact as shown in Fig. 3 & Fig. 4.
In the drug content evaluation, the official standard recommends a
range of 90 - 110% drug content [19]
and from the study, all ibuprofen tablets prepared using the various
starches concentration of 2%, 4% and 6% w/v of ginger and cassava starches was
within the recommended limits. This also depicts that no interaction occurred
between the excipients and the active pharmaceutical ingredient
(API).
CONCLUSIONS-
Ginger starch has been assessed to have good binding property than
cassava starch hence could be a good excipient with a
probable disintegrant property, based on the
physicochemical and qualitative analysis of the granules and tablets produced
with it. With the result obtained from the analysis, therefore, use of ginger
starch as a binder and a probable disintegrating agent is highly recommendable
for the formulation of ibuprofen tablet especially at concentrations of 4 to 6%
w/w.
Ginger starch should be sourced and formulated at the recommended
percentage (4 to 6%) concentration so as to enhance a quality binding activity
as this will help to cushion the economic effect of the imported synthetic
pharmaceutical binding excipients especially in
developing countries.
ACKNOWLEDGEMENTS- Recognition is given to the laboratory staff of the Department of
Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical
Sciences, University of Port Harcourt, for their technical support and
contribution towards the successful completion of this research work.
CONTRIBUTION
OF AUTHORS- The
correspondence author made 60% contribution to the success of this research
work by the conception /design of the work, data analysis and interpretation,
drafting of the article, critical revision of the article and approval of the
article for publication. The second author has 40% contribution by financial
support and in both data collection and analysis.
REFERENCES
1.
King RE. Tablets in Rermington’s Pharmaceutical Sciences, 15th
edition Mark pub.coy Easton Pennsylvania, 1587. (2016): The global health
issues. The UCL student magazine fourth edition, 1975; 2(1): 167-175.
2.
Gordon ER, Rosarnke TW, Former OE, Anderson NR, Baker GS. In
pharmaceutical dosage forms, tablets Liebermann HK, Lachman
L, Schwattz (Eds) Marcel dekkker, New York, 1990; 2: 83-101.
3.
Naisipuri RN. Evaluation of cocoyam starch as tablet binder and disintegrant Acta- Pharm Helv, 1979; 54(2): 48-53.
4.
Afolanyan MO, Omojola MO Orijajogun
JO, Thomas S. Further physicochemical
characterization of Anchomenes difformis starch. Agriculture and Biology journal of North
America, 2012; 3(1): 31-38.
5.
Ogungbenle HN. Effect of chemical modification on starch of some legume
flours. Pakistan journal of nutrition, 2007; 6(2): 167-171.
6.
Mohammed, BB, nternational Isah AB Apeji YE. The role of acid hydrolysed
cassava starch as a binder on Paracetamol tablets. International journal of
pharmaceutical research and innovation, 2011;
426-9.
7.
Talele PB, Sharma KS, Dalvi PB, Nandan SS. Isolation of starch from ginger rhizomes (Zingiber officinalis). Journal of pharmacognosy
and phytochemistry, 2015; 3(6): 65 - 7.
8.
Okezie BO, Koswsikoski FV. Cassava as a food.
Critical review of food sciences, nutrition, 1982; 17: 259-275.
9.
Nyerhovwo JT. Biotechnology issues for developing countries, Cassava, the
future of starch. Electronic Journal of Biotechnology, 2004; 7(1): 2717-3458.
10. Saleh AH, Khali M, Sewsan el-Marey. Stability of hyoscyamine in some BPC mixtures. Journal of Pharmacy,
Pharmacology, 1978; 4: 121-145.
11. Wahbi AA, Hassan E Handy D, Whamis E and Barray M.
Spectrometric method for the determination of ibuprofen in tablets. Pak. S Pharm Sci, 2015; 18(4): 1-6.
12. Sandeep N, Gupta MM. A review on immediate drug release dosage
form. Journal of drug delivery,
therapeutics, 2013; 3(2): 163-174.
13. Nagashree K. Solid dosage forms,
Tablets, Research, Reviews. Journal of
Pharmaceutical Analysis, 2015; 2347-2360.
14. Osasuma T, Takauchi
Y Takauchi H. Characterization of tableting
properties measured with multifunctional compression instrument for several
pharmaceutical excipients and actual tablet
formulation. Int J Pharm,
2016; 10(1): 195-202.
15. Staniforth JN. In, Aulton ME (ed). Pharmaceutics,
the design and manufacture of medicines, 3rd edition Churchill
living stone, and practice of pharmacy (20th edition), 2000;
800-865.
16. Brook DB, Marshal IK. Crushing strength of compressed tablets 1.
Comparison of tester J pharm sci., 1968; 57(3):
481-4.
17. Shaltom E, leonard
GS. Effects of intra and extra-granular maize starch on disintegration of
compressed tablets. Journal of Pharmacy and Pharmacology, 1972; 24(10); 798 - 803.
18. Olayemi FO, Ajibade TO, Arowolo R.
Phytochemical screening and toxicity studies on the methanolic extract of Moringa oleifera. J
Complement Integr Med., 2013; 10(1): 45-62.
19. Wang X Gui F Younazawa
Y Surada H. Preparation and evaluation of high drug
content particles. Drug Dev Ind Pharm,
2003; 20(10): 109-18.